Pharmacokinetics of methotrexate in responders and non responders rheumatoid arthritis patients on methotrexate therapy.

被引：0
|
作者：
Spano, A
Capone, D
Loi, G
Gentile, A
Bossa, RD
Palmicro, G
Celiento, G
Basile, V
Oriente, A
Del Puente, N
Oriente, P
机构：
来源：
ARTHRITIS AND RHEUMATISM | 2000年 / 43卷 / 09期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
1652
引用
收藏
页码：S342 / S342
页数：1
相关论文
共 50 条
  • [1] Combination of ciclosporine plus methotrexate in non-responders to methotrexate alone in rheumatoid arthritis. A retrospective analysis
    Neeck, G
    Schacht, P
    Keysser, M
    ANNALS OF THE RHEUMATIC DISEASES, 2005, 64 : 415 - 415
  • [2] THE IMPORTANCE OF TREATMENT STRATEGY FOR THE OUTCOME OF EARLY RHEUMATOID ARTHRITIS PATIENTS NOT RESPONDERS TO THE FIRST LINE THERAPY WITH METHOTREXATE
    Fedele, Anna Laura
    Tolusso, Dario Bruno Barbara
    Petricca, Luca
    Ferraccioli, Gianfranco
    Gremese, Elisa
    ANNALS OF THE RHEUMATIC DISEASES, 2019, 78 : 1578 - 1579
  • [3] Efficacy Of Adalimumab Plus Methotrexate Therapy In Rheumatoid Arthritis Non-Responders Receiving Methotrexate Monotherapy Or Adalimumab Combination Therapy: Results From The Optima Trial
    Smolen, Josef S.
    van Vollenhoven, Ronald F.
    Fleischmann, Roy
    Emery, Paul
    Florentinus, Stefan
    Rathmann, Suchitrita S.
    Cardoso, Anabela
    Kupper, Hartmut
    Kavanaugh, Arthur
    ARTHRITIS AND RHEUMATISM, 2013, 65 : S999 - S1000
  • [4] EFFICACY OF ADALIMUMAB PLUS METHOTREXATE THERAPY IN RHEUMATOID ARTHRITIS NON-RESPONDERS RECEIVING METHOTREXATE MONOTHERAPY OR ADALIMUMAB COMBINATION THERAPY: RESULTS FROM THE OPTIMA TRIAL
    Smolen, Josef S.
    van Vollenhoven, Ronald F.
    Fleischmann, Roy
    Emery, Paul
    Florentinus, Stefan
    Rathmann, Suchitrita S.
    Cardoso, Anabela
    Kupper, Hartmut
    Kavanaugh, Arthur
    RHEUMATOLOGY, 2014, 53 : 89 - 89
  • [5] METHOTREXATE PHARMACOKINETICS IN PATIENTS WITH RHEUMATOID-ARTHRITIS
    SINNETT, MJ
    GROFF, GD
    RADDATZ, DA
    FRANCK, WA
    BERTINO, JS
    JOURNAL OF RHEUMATOLOGY, 1989, 16 (06) : 745 - 748
  • [6] Pharmacokinetics of Oral Methotrexate in Patients With Rheumatoid Arthritis
    Dalrymple, Judith M.
    Stamp, Lisa K.
    O'Donnell, John L.
    Chapman, Peter T.
    Zhang, Mei
    Barclay, Murray L.
    ARTHRITIS AND RHEUMATISM, 2008, 58 (11): : 3299 - 3308
  • [7] INDOMETHACIN IN RHEUMATOID-ARTHRITIS - CLINICAL AND BIOCHEMICAL EFFECTS AND PHARMACOKINETICS IN RESPONDERS AND NON-RESPONDERS
    ORME, MLE
    BABER, N
    HALLIDAY, LDC
    KEENAN, J
    SIBEON, R
    VANDENHEUVEL, W
    LITTLER, T
    ANNALS OF THE RHEUMATIC DISEASES, 1978, 37 (06) : 575 - 576
  • [8] Combination treatment with tacrolimus (Prograf; FK506) and methotrexate (MTX) in rheumatoid arthritis patients who are partial responders to methotrexate.
    Kremer, J
    Habros, J
    Kolba, K
    Kaine, J
    Berton, MA
    Mekki, Q
    Mengle-Gaw, L
    Schwartz, B
    Wisemandle, W
    ARTHRITIS AND RHEUMATISM, 2002, 46 (09): : S515 - S515
  • [9] The secondary addition of methotrexate partial responders to etanercept alone is effective in severe rheumatoid arthritis
    Cohen, J
    Zaltni, S
    Kaiser, MJ
    Jorgensen, C
    Bozonnat, MC
    Daurès, JP
    Sany, J
    ANNALS OF THE RHEUMATIC DISEASES, 2003, 62 : 167 - 168
  • [10] Secondary addition of methotrexate to partial responders to etanercept alone is effective in severe rheumatoid arthritis
    Cohen, JD
    Zaltni, S
    Kaiser, MJ
    Bozonnat, MC
    Jorgensen, C
    Daurès, JP
    Sany, J
    ANNALS OF THE RHEUMATIC DISEASES, 2004, 63 (02) : 209 - 210
12345